INNOVO®
Atlantic Therapeutics Announces FDA Clearance for Over-the-Counter Use of INNOVO®
Atlantic Therapeutics reports this approval represents a major milestone that will be a key value driver for Atlantic Therapeutics.
Atlantic Therapeutics To Launch INNOVO® – Novel Therapeutic Device For Stress Urinary Incontinence
4/9/19: INNOVO was approved by the United States Food and Drug Administration on November 13, 2018, and is the first ever transcutaneous electrical stimulator cleared by the FDA, offering U.S. women a safe, clinically effective and non-invasive choice to treat stress urinary incontinence
